QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced Sucraid® (sacrosidase) Oral Solution has been shown to be 81% effective in treating patients with Congenital Sucrase-Isomaltase Deficiency (CSID) when used appropriately.1 Eligible patients can now try Sucraid® for free with a 4-day trial offer through their medical provider.
CSID is a rare genetic condition primarily diagnosed through clinical evaluation, requiring a thorough review of the patient's medical history and symptoms. It is characterized by chronic symptoms triggered by the consumption of sucrose (sugar), including gas, bloating, diarrhea, and more.
Testing can support a CSID diagnosis, but it's important to note that other factors may cause sucrose intolerance. False positives and false negatives can occur, making clinical evaluation crucial to ensure accurate diagnosis and effective treatment for this life altering condition.
Sucraid® is specifically designed to help patients with CSID by providing the enzyme sacrosidase, which aids in breaking down sucrose. When used by the right patients, Sucraid® offers significant relief, with clinical studies demonstrating an 81% effectiveness rate.1
How to Try Sucraid®:
Healthcare providers can access a free 4-day trial of Sucraid® to determine its suitability for their condition. This trial provides an opportunity to experience how Sucraid® can alleviate the symptoms of CSID and improve quality of life. Testing can assist with diagnosis, but CSID remains largely a clinical diagnosis.
About CSID
People with CSID, commonly known as Sucrose (sugar) Intolerance, are unable to properly digest sucrose (table sugar), which is found in foods like ice cream, apples, cake, and corn. In adolescents and adults, CSID has been characterized by symptoms of bloating, gas, diarrhea, abdominal cramps, and nausea, which overlap with common irritable bowel syndrome (IBS) symptoms. In infants, CSID classically presents as explosive watery diarrhea, failure to thrive, diaper rash, irritability, and acidic stools.
Indication:
Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.
For more information please visit, www.qolmed.com
